Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Jun 2007 14:00

Huveaux PLC26 June 2007 26 June 2006 HUVEAUX PLC TRADING UPDATE Huveaux is today making the following trading update ahead of its half-yearresults announcement which is expected to be made on 26 July. While EBITDA for 2007 is expected to slightly exceed the level achieved in 2006,this is below current market expectations. Healthcare Division Our Healthcare Division in France has seen a significant drop in sales revenueas compared to the first half of 2006. This is as a direct result ofpharmaceutical companies cutting their advertising budgets across the board inresponse to the sharp rise in generic drugs. The revenues from our ContinuingMedical Education accredited publications and other product offerings havestarted to flow through, but these have not been sufficient to offset the impactfrom the decline in pharmaceutical advertising. Accordingly, the outlook for theyear is that sales and EBITDA of the Healthcare Division will be significantlylower than in 2006. Nevertheless, the expected performance of the Healthcare Division in 2007 willstill give at least a 15% pre-tax return on the original cost of acquisition -significantly in excess of our cost of capital. Political Division The Political Division continues to make progress with good organic revenuegrowth. Its market-leading positions in London, Paris and Brussels continue tobe strengthened and the outlook for the year remains very positive. Learning Division This division has been impacted by training budget cuts in GovernmentDepartments during the first half of 2007. Sales have started to recover duringthe past few weeks and the outlook is for a strong second half performance.Nevertheless, for 2007 as a whole, sales and EBITDA are likely to be lower thanin 2006. Education Division The Education Division is making very good progress with strong organic growthin both sales and EBITDA. Under Huveaux's new ownership, the historic revenuedecline at Letts has been reversed and Lonsdale's sales are up significantly onlast year, including an encouraging increase in Science curriculum sales. Leckie& Leckie has also produced an outstanding performance with record profits andincreased market share driven by an expanded portfolio. The 2007 outlook for theEducation Division is therefore excellent. The Company continues to make strategic progress in key areas and is stronglycommitted to increasing shareholder value. Accordingly, the complementaryacquisition of the European Public Affairs Directory was completed in May andour small contract publishing business in the Healthcare Division was sold inJune. A review of our paper and print costs is also likely to have a beneficialeffect on the 2008 results. Management has initiated a recovery programme and further details will beincluded in the half-year results announcement. END For further information, please contact: Huveaux John van KuffelerExecutive Chairman 020 7245 0270 Gerry MurrayChief Executive Officer Dan O'BrienGroup Finance Director Finsbury James Leviton 020 7251 3801Don Hunter About Huveaux: Huveaux PLC is a public limited company listed on the Alternative InvestmentMarket (ticker HVX.L). The Company was formed in 2001 with the objective of building a substantial,high-quality media group. Huveaux has completed and successfully integrated 13acquisitions over the past six years and employs more than 500 staff in London,Paris, Brussels, Edinburgh and four other UK regional offices. The Group now consists of four Divisions, each of which has strong brands andmarket leading positions: Political Division The market leader in political business-to-business publishing in the UK and EU,serving both the political and public affairs communities. The Divisioncomprises Dods Parliamentary Companion, The House Magazine, Epolitix.com andnumerous other political magazines, reference books, monitoring products andrevenue-generating websites as well as events, awards and recruitment services. Healthcare Division One of the leading providers of specialist B2B publications and online educationfor the medical sector in France. The Division comprises Panorama du Medecin, aleading weekly magazine for French doctors, Le Concours Medical and La Revue duPraticien, market-leading Continuing Medical Education magazines, Egora.fr, theleading medical information website, a medical conference business and a numberof other magazines and reference materials. Learning Division A leading provider of resources to learning communities in the UK, includinge-learning solutions for the public and private sector and blended learningsolutions, seminars and events for the political, public affairs and trainingmarkets. The Division comprises Epic, the UK market leader in e-learning, The TJmagazine and the highly acclaimed Westminster Explained conferences and seminarsbusiness. Education Division (established 1 January 2007) The leading supplier of study aids and revision guides in the UK, with fullproduct coverage across all subjects and stages of the entire curriculum in UKschools. The Division comprises Lonsdale, Letts Educational and Leckie & Leckie. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20214:05 pmRNSHolding(s) in Company
16th Apr 202111:30 amRNSResult of General Meeting
1st Apr 20217:00 amRNSPosting of Circular and Notice of GM
30th Mar 20217:01 amRNSChange of Name and Share Capital Reorganisation
30th Mar 20217:00 amRNSTrading Update
30th Nov 20207:00 amRNSHalf-year Report
26th Nov 202011:35 amRNSBoard Changes
12th Oct 20204:23 pmRNSHolding(s) in Company
29th Sep 202012:21 pmRNSResult of AGM
4th Sep 202012:31 pmRNSAnnual Financial Report
3rd Sep 20207:02 amRNSFinal Results
3rd Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
5th Aug 20202:02 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSIssue of Shares and Director / PDMR Dealing
1st Jul 202010:52 amRNSDirectorate Change
18th Jun 20207:00 amRNSDr David Hammond
1st Jun 20202:06 pmRNSBoard Appointments
1st Jun 20207:00 amRNSUpdated Debt Facilities
23rd Apr 20207:06 amRNSAppointment of CFO and COVID-19 Update
18th Mar 20205:46 pmRNSAIM Rule 17 Notification
24th Feb 20203:47 pmRNSDirectorate Change
22nd Jan 20202:52 pmRNSDirectorate Change
22nd Jan 20207:00 amRNSTrading Update
29th Oct 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSChange of Adviser
25th Sep 20198:59 amRNSAIM Rule 17 Schedule Two (g) Update
2nd Sep 20197:00 amRNSDirectorate Change
29th Aug 20194:07 pmRNSResult of AGM
23rd Jul 20197:00 amRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20191:42 pmRNSCompletion of Acquisition
18th Jul 20198:48 amRNSDirector/PDMR Shareholding
18th Jul 20198:46 amRNSAnnual Financial Report
16th Jul 201910:39 amRNSResult of General Meeting and Open Offer
28th Jun 20198:47 amRNSGeneral Meeting & Open Offer Timetable
28th Jun 20197:00 amRNSAcquisition, Fundraising and Notice of GM
28th Jun 20197:00 amRNSFinal Results
11th Jun 20197:00 amRNSAcquisition of Meritgroup
10th Jun 20197:00 amRNSResponse re. Press Speculation
21st May 20197:00 amRNSAppointment of Chief Revenue Officer
29th Apr 20197:00 amRNSAppointment of Chief Information Officer
21st Jan 20197:00 amRNSTrading Statement
5th Dec 20181:50 pmRNSHolding(s) in Company
5th Dec 20181:50 pmRNSHolding(s) in Company
14th Nov 20187:00 amRNSHalf-year Report
21st Sep 201811:17 amRNSLong Term Incentive Plan
14th Aug 201812:39 pmRNSDirectorate Change
7th Aug 20184:14 pmRNSDirector/PDMR Shareholding
1st Aug 20189:52 amRNSDirectorate Change
1st Aug 20189:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.